ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1437

Journal of Clinical & Experimental Pathology received 1437 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Jason Cheng

Jason Cheng Head of Epigenetic Laboratory, Department of Pathology, University of Michigan, USA

Biography

Jason Cheng is currently working as a Professor. The author's research interests include Clinical Pathology, Histopathology, Hemato Pathology, Surgical Pathology, Diagnosis. The author is serving as an editorial member and reviewer of several international reputed journals. The author has successfully completed his administrative responsibilities. The author has authorized many research articles/books related to Clinical Pathology, Experimental Pathology.

Research Interest

Dr. Jason Cheng’s research is aimed at understanding epigenetic and genetic controls of both normal and abnormal hematopoiesis, especially, myelopoiesis. Dr. Jason Cheng’s laboratory is currently developing and implementing new technologies for genome-wide profiling of epigenetic biomarkers/signatures and exploring their potential clinical use for assisting diagnosis, prognosis and therapeutic management of myelodysplastic syndrome (MDS), leukemia and other diseases. Another major effort in Dr. Cheng’s laboratory is to elucidate pathogenetic mechanisms underlying epigenetic alterations in MDS, leukemia and bone marrow diseases. Dr. Jason Cheng’s clinical interests include general hematopathology, myelodysplastic syndrome (MDS), myeloproliferative neoplasms, other bone marrow diseases and lymphoid disorders.

Publications

Global Speakers in the subject

Global Experts in the subject

Top